The overall objective of this project is to develop bacteriochlorophyll- carotenoid based molecular beacons (BChl-MB) as prostate cancer (CaP)-specific photosensitizers for photodynamic therapy (PDT). The basic concept underlying this proposal is depicted in Figure 1. We propose to synthesize a molecular beacon (MB) consisting of any antisense oligodeoxynucleotide (AS-ON) sequence complementary to an mRNA specific for the target cancer cells. The MB contains a single- stranded DNA that can form a stem-loop structure. The loop sequence is an AS-ON. The stem is formed by the annealing of two complementary arm sequences that are on either side of the loop sequence. A dye (D) is attached to the end of one arm and a quencher (Q) is similarly attached to the other end. Proximity of D and Q quenches fluorescence and photoreactivity of the dye by energy transfer. In the presence of the tumor specific mRNA, the MB hybridizes with the mRNA, disrupting the hydrogen bonds of the stem. The quencher is removed from the immediate vicinity of the dyne. Upon irradiating with light, the dye emits fluorescence and generates cytotoxic singlet oxygen. The beacon serves both as a directed photodynamic therapy (PDT) agent and as a tumor specific diagnostic agent. We are proposing to synthesize BCh1-Mbs [in Fig. 1 D= bacteriochlorophyll (BCh1), Q= carotenoid (Car)] containing stem-loop AS-ON sequence targeted at the DD3 mRNA.. We have selected DD3 as the molecular target because it is one of the most CaP- specific genes described to date and is highly over-expressed in CaP. Such MB based PDT agents should be CaP-specific. We will focus on the synthesis of the BChl-MB that can hybridize with DD3 mRNA resulting in the significant increase of the fluorescence and the singlet oxygen production. We will develop cell-specific peptides as delivery reagents fort Bchl-MB and confirm that this agent reaches the target sites. Finally, we will validate the concept of MB based PDT agents in two human prostate cancer cell lines. Finally, we will validate the concept of MB based PDT agents in tow human prostate cancer cell lines, LNCaP (over-expressing DD3) and DU145 (not expressing DD3).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA095330-01
Application #
6465934
Study Section
Special Emphasis Panel (ZCA1-SRRB-D (J1))
Program Officer
Wong, Rosemary S
Project Start
2002-04-02
Project End
2004-03-31
Budget Start
2002-04-02
Budget End
2003-03-31
Support Year
1
Fiscal Year
2002
Total Cost
$158,500
Indirect Cost
Name
University of Pennsylvania
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Chen, Juan; Lovell, Jonathan F; Lo, Pui-Chi et al. (2008) A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production. Photochem Photobiol Sci 7:775-81
Stefflova, Klara; Chen, Juan; Zheng, Gang (2007) Killer beacons for combined cancer imaging and therapy. Curr Med Chem 14:2110-25
Stefflova, Klara; Chen, Juan; Zheng, Gang (2007) Using molecular beacons for cancer imaging and treatment. Front Biosci 12:4709-21
Zheng, Gang; Chen, Juan; Stefflova, Klara et al. (2007) Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation. Proc Natl Acad Sci U S A 104:8989-94
Chen, Juan; Stefflova, Klara; Niedre, Mark J et al. (2004) Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. J Am Chem Soc 126:11450-1
Zhang, Zhihong; Blessington, Dana; Li, Hui et al. (2004) Redox ratio of mitochondria as an indicator for the response of photodynamic therapy. J Biomed Opt 9:772-8
Chen, Y; Zheng, G; Zhang, Z H et al. (2003) Metabolism-enhanced tumor localization by fluorescence imaging: in vivo animal studies. Opt Lett 28:2070-2
Zhang, Min; Zhang, Zhihong; Blessington, Dana et al. (2003) Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. Bioconjug Chem 14:709-14